Evidence map›Paper›PMID 33828260›Full record

Trial reportBritish journal of cancer2021

The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO).

Cecilia Margareta Lund, Kirsten Kjeldgaard Vistisen, Anne Pries Olsen, Pernille Bardal, Martin Schultz, Troels Gammeltoft Dolin, Finn Rønholt, Julia Sidenius Johansen, Dorte Lisbeth Nielsen

Registry-linked trialAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02748811 (Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer), which is not on this map. Cited by 88 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02748811 nacompletednot on this map

Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer

TypeinterventionalSponsorUniversity of CopenhagenRan2015 to 2019Enrolled140ConditionsColorectal NeoplasmsArmsIntervention group
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Predictive value of the Cancer and Aging Research Group Score for chemotherapy toxicities in older adults with cancer: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  3. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Guideline
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Decision making and outcomes in colorectal cancer and frailty: the DeCaF study.Annals of the Royal College of Surgeons of England · 2026
    Article
  14. Personalizing cancer care for older adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cecilia Margareta LundDepartment of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark. Cecilia.margareta.lund.01@regionh.dk.ORCID http://orcid.org/0000-0002-9894-029X
Kirsten Kjeldgaard VistisenDepartment of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Copenhagen, Denmark.
Anne Pries OlsenDepartment of Physiotherapy and Occupational Therapy, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Pernille BardalNutritional and Dietetic Research Unit, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Martin SchultzDepartment of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Troels Gammeltoft DolinDepartment of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Finn RønholtDepartment of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Julia Sidenius JohansenDepartment of Medicine, Copenhagen University Hospital, Herlev and Gentofte, Copenhagen, Denmark.
Dorte Lisbeth NielsenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlder patients with colorectal cancer (CRC) experience chemotherapy dose reductions or discontinuation. Comprehensive geriatric assessment (CGA) predicts survival and chemotherapy completion in patients with cancer, but the benefit of geriatric interventions remains unexplored.

methodsThe GERICO study is a randomised Phase 3 trial including patients ≥70 years receiving adjuvant or first-line palliative chemotherapy for CRC. Vulnerable patients (G8 questionnaire ≤14 points) were randomised 1:1 to CGA-based interventions or standard care, along with guideline-based chemotherapy. The primary outcome was chemotherapy completion without dose reductions or delays. Secondary outcomes were toxicity, survival and quality of life (QoL).

resultsOf 142 patients, 58% received adjuvant and 42% received first-line palliative chemotherapy. Interventions included medication changes (62%), nutritional therapy (51%) and physiotherapy (39%). More interventional patients completed scheduled chemotherapy compared with controls (45% vs. 28%, P = 0.0366). Severe toxicity occurred in 39% of controls and 28% of interventional patients (P = 0.156). QoL improved in interventional patients compared with controls with the decreased burden of illness (P = 0.048) and improved mobility (P = 0.008).

conclusionGeriatric interventions compared with standard care increased the number of older, vulnerable patients with CRC completing adjuvant chemotherapy, and may improve the burden of illness and mobility.

trial registrationClinicalTrials.gov ID: NCT02748811.

Indexed as

Frail ElderlyAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColorectal NeoplasmsComorbidityDenmarkFemaleGeriatric AssessmentHumansMalePalliative CareQuality of LifeTreatment Outcome

Identifiers

PMID33828260
PMCPMC8185087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.